Trials / Completed
CompletedNCT03919422
Paravertebral Block for Proximal Humeral Fracture Surgery
Effectiveness of Additional Thoracic Paravertebral Block in Improving Anesthetic Effects of Regional Anesthesia for Proximal Humeral Fracture Surgery in Elderly Patients: Study Protocol for a Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Shanghai 6th People's Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effects of T2 paravertebral block block improving interscalene brachial plexus block and superficial cervical plexus block on the relief of pain intensity during elderly proximal humerus fracture fixation surgery. The brachial plexus and cervical plexus block(IC block) will be performed in half of participants, while the T2 paravertebral block combined with IC block will be performed in the other half.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | T2 paravertebral block | Ultrasound guided T2 thoracic paravertebral block is added in ICTP group. After interscalene brachial plexus block and superficial cervical plexus block have been administrated, selective 2nd thoracic nerve root(T2) will be blocked with 10 ml of 0.25% ropivacaine(naropin). |
| PROCEDURE | interscalene brachial plexus block and superficial cervical plexus block | An ultrasound-guided IC block using an ultrasound machine (Sonosite, USA), and an linear array probe with a sterile cover and a 22G(Gauge) block needle is performed. An in-plane approach, advancing the needle along the longitudinal axis of the ultrasound transducer and visualizing the entire shaft is employed. Twenty ml of 0.375% ropivacaine(naropin) is injected around brachial plexus and 10 ml of 0.25% ropivacaine around superficial cervical plexus. |
Timeline
- Start date
- 2019-05-05
- Primary completion
- 2020-08-25
- Completion
- 2020-08-26
- First posted
- 2019-04-18
- Last updated
- 2021-01-05
- Results posted
- 2021-01-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03919422. Inclusion in this directory is not an endorsement.